Page 7 of 11
The Journal of Organic Chemistry
1724, 1651, 1455, 1196, 1071, 735, 697; HRMS (TOF ES+) 11.8 Hz, J = 2.5 Hz, 1H), 3.74 (d, J = 11.8 Hz, J = 2.5 Hz, 1H),
+
m/z: [M+Na]+ Calcd for C29H27F5NaO4 557.1722; Found 2.45 (m, 1H), 2.27 (m, 1H); 13C{1H} NMR (100.6 MHz,
1
2
3
4
5
557.1724.
CD3OD) δ 160.9, 151.3, 145.9 (t, J = 9.4 Hz), 120.5 (appdt, J =
285.0 Hz, 37.7 Hz), 103.0 (bs), 89.4, 87.7, 71.8, 62.1, 42.3; 19F
NMR (376.5 MHz, CD3OD) δ –85.6 (bs, 3F), –114.4 (m, 2F).
1,5-Anhydro-3,6-di-O-acetyl-2-deoxy-4-O-(2,3,4,6-tetra-O-
acetyl-β-D-galactopyranosyl)-2-pentafluoroethyl-D-arabino-
hex-1-enitol (2e). The title compound was prepared following
6-Pentafluoroethyl-1,3-dimethyluracil (2h). The title com-
the general procedure above, starting from 3,6-di-O-acetyl-2- pound was prepared following the general procedure above,
iodo-4-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-D-glucal starting from 6-iodo-1,3-dimethyluracil 1h38 (30.8 mg, 0.116
1e32 (59 mg, 0.086 mmol) and CuC2F5 (0.4 M in DMF, 0.39 mL, mmol) and CuC2F5 (0.4 M in DMF, 0.56 mL, 0.23 mmol). After
0.17 mmol). After 48 h at 60 ºC, standard workup and filtration 6 h at 50 ºC, standard workup and filtration through a short path
through a short path of SiO2 (1:1 EtOAc/hexane) afforded 2e of SiO2 (1:9 EtOAc/hexane) afforded 2h (24 mg, 80%) as a
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
1
(52 mg, 89%) as a colorless syrup. Rf (1:1 EtOAc/hexane): colorless syrup. Rf (1:9 EtOAc/hexane): 0.16; H NMR (400
0.25; [α]D20 +4.6 (c 1.02, CHCl3); 1H NMR (400 MHz, CDCl3) δ MHz, CDCl3) δ 6.20 (s, 1H), 3.52 (t, J = 2.2 Hz, 3H), 3.38 (s,
7.09 (bs, 1H), 5.73 (bs, 1H), 5.37 (d, J = 3.4 Hz, J = 1.0 Hz, 3H); 13C{1H} NMR (100.6 MHz, CDCl3) δ 160.9, 152.0, 139.9
1H), 5.17 (dd, J = 10.4 Hz, J = 7.9 Hz, 1H), 5.01 (dd, J = 10.4 (t, J = 24.3 Hz), 118.2 (qt, J = 287.1 Hz, J = 40.1 Hz), 110.8 (tq,
Hz, J = 3.4 Hz, 1H), 4.70 (d, J = 7.9 Hz, 1H), 4.53–4.47 (m, J = 259.4 Hz, J = 40.1 Hz), 105.5 (t, J = 8.1 Hz), 33.6 (m), 28.7;
1H), 4.32 (dd, J = 12.0 Hz, J = 8.4 Hz, 1H), 4.21–4.07 (m, 3H), 19F NMR (376.5 MHz, CDCl3) δ –81.6 (bs, 3F), –111.4 (m, 2F);
4.02–3.97 (m, 2H), 2.14 (s, 3H), 2.11 (s, 3H), 2.03 (s, 6H), 2.02 FTIR–ATR (neat, νmax) 3110, 2960, 2917, 1849, 1719, 1667,
(s, 3H), 1.97 (s, 3H); 13C{1H} NMR (100.6 MHz, CDCl3) δ 1440, 1369, 1200, 1146, 1078, 998, 938, 831, 744; HRMS
170.6, 170.5, 170.4, 170.2, 169.6, 169.2, 150.8 (t, J = 10.2 Hz), (QTOF EI+) m/z: [M]+ Calcd for C8H7F5N2O2+ 258.0428; Found
119.0 (qt, J = 286.6 Hz, J = 40.4 Hz), 113.2 (tq, J = 253.9 Hz, J 258.0430.
2-(Pentafluoroethyl)-1H-indole (2i).39 The title compound
was prepared following the general procedure above, starting
from 2-iodoindole 1i40 (26 mg, 0.107 mmol) and CuC2F5 (0.4 M
in DMF, 0.52 mL, 0.22 mmol). After 6 h at 50 ºC standard
workup and filtration through a short path of SiO2 (1:9
EtOAc/hexane) afforded 2i (21.5 mg, 86%) as a white solid. Rf
= 40.4 Hz), 101.7, 99.1 (t, J = 24.0 Hz), 74.8, 72.7, 71.3, 70.9,
68.9, 67.0, 61.4, 61.3, 61.2, 20.9, 20.8, 20.7, 20.7, 20.6; 19F
NMR (376.5 MHz, CDCl3) δ –84.7 (bs, 3F), –112.9 (d, J =
275.2 Hz, 1F), –115.6 (d, J = 274.3 Hz, 1F); FTIR–ATR (neat,
νmax) 2984, 1742, 1656, 1369, 1204, 1075, 1046, 1019, 956,
899, 736; HRMS (TOF ES+) m/z: [M+Na]+ Calcd for
C26H31F5NaO15+ 701.1475; Found 701.1476.
1
(1:9 EtOAc/hexane): 0.37; H NMR (400 MHz, CDCl3) δ 8.41
Methyl 5-acetamido-4,7,8,9-tetra-O-acetyl-2,6-anhydro-3,5- (bs, 1H), 7.71 (d, J = 8.0 Hz, 1H), 7.46 (m, 1H), 7.35 (m, 1H),
dideoxy-3-pentafluoroethyl-D-glycero-D-galacto-non-2-enonate
7.22 (m, 1H), 6.98 (bs, 1H); 13C{1H} NMR (100.6 MHz,
(2f). The title compound was prepared following the general CDCl3) δ 136.1, 127.0, 125.0, 124.0 (t, J = 29.1 Hz), 122.2,
procedure above, starting from methyl 5-acetamido-4,7,8,9- 121.3, 119.0 (qt, J = 285.7 Hz, J = 38.9 Hz), 111.8, 111.0 (tq, J
tetra-O-acetyl-2,6-anhydro-3,5-dideoxy-3-iodo-D-glycero-α-D-
= 251.3 Hz, J = 38.9 Hz), 106.2 (t, J = 4.9 Hz); 19F NMR (376.5
galacto-non-2-enonate 1f32 (40 mg, 0.066 mmol) and CuC2F5 MHz, CDCl3) δ –84.5 (t, J = 3.2 Hz, 3F), –111.9 (m, 2F).
(0.4 M in DMF, 0.30 mL, 0.13 mmol). After 40 h at 60 ºC,
standard workup and filtration through a short path of SiO2 (7:3
tert-Butyl-5-fluoro-3-(pentafluoroethyl)-1H-indole-1-
carboxylate (2j). The title compound was prepared following
the general procedure above, starting from 1j41 (27 mg, 0.076
mmol) and CuC2F5 (0.4 M in DMF, 0.43 mL, 0.18 mmol). After
16 h at 40 ºC, standard workup and filtration through a short
path of SiO2 (hexane) afforded 2j (21 mg, 86%) as a white sol-
EtOAc/hexane) afforded 2f (38.1 mg, 95%) as a white foam. Rf
20
1
(EtOAc): 0.47; [α]D –14.4 (c 0.25, CH2Cl2); H NMR (400
MHz, CDCl3) δ 5.82 (d, J = 8.4 Hz, 1H), 5.76 (d, J = 6.5 Hz,
1H), 5.54 (dd, J = 6.0 Hz, J = 3.6 Hz, 1H), 5.22 (td, J = 6.0 Hz,
J = 3.0 Hz, 1H), 4.55–4.46 (m, 2H), 4.36 (dd, J = 12.5 Hz, J =
3.0 Hz, 1H), 4.11 (dd, J = 12.5 Hz, J = 6.0 Hz, 1H), 3.83 (s,
3H), 2.10 (s, 3H), 2.07 (s, 3H), 2.05 (s, 3H), 2.03 (s, 3H), 1.93
(s, 3H); 13C{1H} NMR (100.6 MHz, CDCl3) δ 170.7, 170.4,
169.8, 169.8, 161.2, 153.3 (dd, J = 7.1 Hz, J = 7.1 Hz), 118.8
(qt, J = 287.7 Hz, J = 40.2 Hz), 113.0 (dd, J = 256.9 Hz, J =
40.2 Hz), 101.2 (dd, J = 25.3 Hz, J = 21.8 Hz), 77.7, 69.8, 66.8,
65.1, 61.8, 53.5, 47.1, 23.1, 20.9, 20.8, 20.7, 20.6; 19F NMR
(376.5 MHz, CDCl3) δ –81.6 (bs, 3F), –106.1 (d, J = 281.0 Hz,
1F), –110.6 (d, J = 281.0 Hz, 1F); FTIR–ATR (neat, νmax) 3276,
1749, 1656, 1541, 1438, 1371, 1207, 1048, 1027, 965; HRMS
(TOF ES+) m/z: [M+Na]+ Calcd for C21H26F3NNaO12+ 564.1299;
Found 564.1307.
1
id. Rf (1:9 EtOAc/hexane): 0.50; mp 74–76 ºC; H NMR (400
MHz, CDCl3) δ 8.16 (bdd, J = 9.1 Hz, J = 4.4 Hz, 1H), 7.94 (bs,
1H), 7.33 (bd, J = 8.8 Hz, 1H), 7.10 (td, J = 9.1 Hz, J = 2.6 Hz,
1H), 1.69 (s, 9H); 13C{1H} NMR (100.6 MHz, CDCl3) δ 159.7
(d, J = 240.9 Hz), 148.7, 131.9, 128.7 (t, J = 8.1 Hz), 127.0 (dt,
J = 11.2 Hz, J = 2.6 Hz), 119.3 (qt, J = 285.7 Hz, J = 40.1 Hz),
116.8 (d, J = 9.3 Hz), 113.9 (d, J = 25.2 Hz), 113.0 (tq, J =
250.4 Hz, J = 40.1 Hz), 109.4 (td, J = 28.0 Hz, J = 4.1 Hz),
106.2 (d, J = 26.2 Hz), 85.8, 28.2; 19F NMR (376.5 MHz,
CDCl3) δ –84.8 (t, J = 2.7 Hz, 3F), –111.2 (bs, 2F), –118.63 (td,
J = 8.8 Hz, J = 4.7 Hz, 1F); FTIR–ATR (neat, νmax) 2984, 1751,
1479, 1454, 1385, 1256, 1203, 1152, 1067, 1026, 962, 854, 811,
+
738; HRMS (QTOF EI+) m/z: [M]+ Calcd for C15H13F6NO2
5-Pentafluoroethyl-2’-deoxyuridine (2g).37 The title com- 353.0850; Found 353.0848.
General Procedure for Quantitative 19F NMR Analysis.
An NMR tube charged with the corresponding solid (hetero)aryl
halide (0.171 mmol) was purged and backfilled with argon three
times. CuC2F5 (0.4 M in DMF, 0.4 mL, 0.26 mmol) and 1,3-
bis(trifluoromethyl)benzene (BTB, 13 µL, 0.084 mmol) were
sequentially added under argon and the NMR tube was capped
with a rubber septum. The reaction mixture was heated in a
silicon oil bath at the indicated temperature and monitored by
pound was prepared following the general procedure above,
starting from 5-iodo-2’-deoxyuridine 1g (44 mg, 0.124 mmol)
and CuC2F5 (0.4 M in DMF, 0.61 mL, 0.25 mmol). After 6 h at
60 ºC, standard workup and filtration through a short path of
SiO2 (9:1 CH2Cl2/MeOH) afforded 2g (34 mg, 79%) as a white
solid. Rf (9:1 CH2Cl2/hexane): 0.26; 1H NMR (400 MHz,
CD3OD) δ 8.82 (bs, 1H), 6.24 (t, J = 6.0 Hz, 1H), 4.41 (dd, J =
9.3 Hz, J = 4.0 Hz, 1H), 3.98 (bd, J = 2.8 Hz, 1H), 3.83 (dd, J =
ACS Paragon Plus Environment